InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Herman James L, Responsable de la Conformité. Director active across 1 company, notably Cumberland Pharmaceuticals INC. Aggregated, 4 filings have been recorded. History available since 17 March 2021. The latest transaction was disclosed on 23 March 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Herman James L
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
1,186 股@ US$1.819.3% 占其流量Common StockSEC:0001214659-24-005215:0
1,280 股@ US$1.9210.9% 占其流量Common StockSEC:0001209191-23-020346:0
1,280 股@ US$2.7422.0% 占其流量Common StockSEC:0001209191-22-026142:0
2,560 股@ US$3.2248.2% 占其流量Common StockSEC:0001209191-21-039926:0
4 条申报中的 4 条
About Herman James L
James L. Herman is the Vice President and Chief Compliance Officer of Cumberland Pharmaceuticals Inc. In this role, he oversees compliance affairs and ensures that the company adheres to regulatory requirements. Herman brings expertise in regulatory compliance and risk management, contributing to the protection of the company's interests and its stakeholders. His commitment to transparency and accountability is essential to maintain investor confidence.
